We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Proteome Sciences Plc | LSE:PRM | London | Ordinary Share | GB0003104196 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3.51 | 3.02 | 4.00 | - | 1,028 | 08:00:10 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 7.78M | 1.33M | 0.0045 | 7.80 | 10.36M |
Date | Subject | Author | Discuss |
---|---|---|---|
14/11/2023 16:00 | Where is all this box of delights they were banging on about in the latest presentation.Have to say this Mrs S is proving a bigger waste of money than all the other CJP prodigies. | peverill | |
10/11/2023 21:23 | Wasn't it the little dumpy carrot head? | dominiccummings | |
10/11/2023 12:15 | I first invested in PRM in 1999 when it was called Electrophoretics - so I am expecting big things next year as it will be my silver jubilee.I did sell for a decent profit -many moons ago & wisely ( not ) bought back again when their long slide started.I have to be an optimist-but that side of me now wonders whether 2024 may indeed be the year when substantial progress occurs- & I can enjoy the pleasure that a "few bob" will bring to my children & grandchildren? | base7 | |
10/11/2023 10:40 | Aye, never mind the "Toll Booths". I remember in the days of "the last tree standing" that PRM was supposed to have the proteomic field so covered by patents that anyone would have to pay them royalties. What happened to that then? | jeffian | |
10/11/2023 09:27 | What about everyone on the outfield having to pay to get to the cricket strip in the middles? Didn't that work? | dominiccummings | |
10/11/2023 08:20 | So not even jam tomorrow. or 5yrs | madmick | |
10/11/2023 06:54 | Not a hint of PRM mentioned anywhere. | canaletto | |
09/11/2023 15:18 | well if its anything to do with PRM that's at least another 5years away. £5m project launched with aim of having reliable tests within five years to provide quick diagnosis As for as down the back of the sofa, I think that's stuffed with old patents. | madmick | |
09/11/2023 08:32 | Do we have one down the back of a sofa somewhere??? | small crow | |
08/11/2023 20:05 | well & truly strung up by the intangibles | elpirata | |
07/11/2023 20:26 | Randox_Girl 28 Sep '20 - 08:46 - 58175 of 59550 0 6 2 Short delay. Diggle has started selling down OBD in bulk | elpirata | |
07/11/2023 18:45 | OBD up at 30p plus, but how much of Vulpes stake was from 200p area?? | stocktastic | |
07/11/2023 18:42 | I could have sworn that pools2 (jt?) told us Randox was launching the stroke test 'soon' at on at least 20 occasions over the last 20 years. | stocktastic | |
07/11/2023 17:19 | Apparently, in this case, Mr. Market is a mechanism for transferring value from the patents to the in-patients. | jeffian | |
07/11/2023 16:08 | sod shareholder value, lets have some more patents | elpirata | |
07/11/2023 13:13 | I understand from the avatar wasjobber on another thread that it is a ‘strong buy’ for numerous reasons. The avatar, however, has singularly failed to evidence the veracity of these reasons - and tbf, he has been banging the same drum with a spectacular lack of success for a considerable period of time. I hope this helps. Ah Bisto. | monte1 | |
07/11/2023 13:07 | Any shareholder value expected here,or is it still a Directors dream job/Gravy train. | peverill | |
03/11/2023 17:34 | Thanks WJ for the informative posts. 6p this year, 10p+ next. W41 | wrighty41 | |
03/11/2023 10:04 | Excellent time for Proteome Sciences to be opening a new services laboratory in the USA. "emerging technologies in the realm of biomarker discovery services include CRISPR-based methodologies and single-cell analysis" Prominent Player: - Proteome Sciences STRONG BUY | wasjobber | |
02/11/2023 14:49 | Edit duly noted. | monte1 | |
02/11/2023 14:35 | It is probably the only ride that you are going to get. nai, nag, dyor. | monte1 | |
02/11/2023 14:33 | An 18 year project headed by Steven Gygi, Harvard University culminates with 32-plex TMT and a paradigm shift in Mass Spec Quantitative Proteomics. STRONG BUY | wasjobber |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions